Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Rybelsus
Rybelsus
Novo Nordisk's oral diabetes drug cuts heart-related risks by 14% in study
Reuters
Mon, 10/21/24 - 09:39 am
Novo Nordisk
Rybelsus
cardiovascular events
Ozempic linked to lower opioid overdose rate in those with diabetes, study shows
Stat
Wed, 09/25/24 - 12:04 pm
Novo Nordisk
Ozempic
opioid addiction
Rybelsus
type 2 diabetes
The 25 Most Popular Drugs by U.S. Spending
AARP
Fri, 05/10/24 - 11:33 am
prescription spending
Ozempic
Rybelsus
Wegovy
Eliquis
Humira
Novo Nordisk
AbbVie
EMA to Review Diabetes and Weight-Loss Drugs for Suicidal Ideation Risk
BioSpace
Tue, 04/9/24 - 11:11 am
EMA
Europe
diabetes
weight loss
Novo Nordisk
Ozempic
Wegovy
Eli Lilly
Trulicity
Saxenda
Rybelsus
Victoza
Novo Nordisk Seeks to Solidify Its Lead in Diabetes Treatment and Crushing the Market
Motley Fool
Thu, 04/6/23 - 11:29 am
Novo Nordisk
diabetes
Ozempic
Rybelsus
Novo's high-dose Rybelsus win tees up regulatory filings—and new rivalries
Fierce Pharma
Mon, 03/27/23 - 11:23 am
Novo Nordisk
Rybelsus
diabetes
clinical trials
Eli Lilly
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Xtalks
Sun, 01/29/23 - 01:31 pm
television ads
pharma marketing
DTC ads
AbbVie
Rinvoq
Dupixent
Sanofi
Regeneron
Skyrizi
Novo Nordisk
Ozempic
Jardiance
Eli Lilly
Boehringer Ingelheim
Rybelsus
Trulicity
Rexulti
Otsuka
Lundbeck
Tremfya
JNJ
Verzenio
Novo Nordisk's GLP-1 for Type II diabetes approved for first-line treatment
Endpoints
Fri, 01/13/23 - 11:10 am
Novo Nordisk
Rybelsus
semaglutide
FDA
type 2 diabetes
diabetes
ADA 2021: Novo trumpets higher-dose Ozempic data as Lilly competitors loom
Fierce Pharma
Sun, 06/27/21 - 10:57 pm
Novo Nordisk
Ozempic
Eli Lilly
Rybelsus
Trulicity
diabetes
type 2 diabetes
Pharma TV Ad Spending Trends: Companies in the Top Ten this Week
Xtalks
Thu, 05/13/21 - 11:46 pm
DTC ads
television ads
Dupixent
Trulicity
Rybelsus
AbbVie's Humira regains top pharma TV spender spot, while sibling brands Rinvoq and Skyrizi tag along
Fierce Pharma
Wed, 05/5/21 - 10:50 am
AbbVie
Humira
DTC advertising
television ads
Sanofi
Dupixent
Novo Nordisk
Rybelsus
Novo takes the plunge in Alzheimer’s
EP Vantage
Thu, 12/17/20 - 06:20 pm
Novo Nordisk
Rybelsus
Alzheimer's disease
Novo launches type 2 diabetes pill in UK after NICE waives review
Pharmaforum
Tue, 09/1/20 - 10:44 am
Novo Nordisk
UK
type 2 diabetes
diabetes
Rybelsus
semaglutide
NICE
How a cocktail of existing drugs could regenerate insulin-producing cells in diabetes
Fierce Biotech
Thu, 02/13/20 - 10:44 am
diabetes
insulin
Mt Sinai
Novo Nordisk
Ozempic
Rybelsus
Victoza
Eli Lilly
Trulicity
AstraZeneca
Bydureon
Novo Nordisk's diabetes pill Rybelsus to be covered by Express Scripts
Reuters
Fri, 01/17/20 - 11:51 pm
Novo Nordisk
Rybelsus
Express Scripts
PBMs
ICER Warns of ‘Short-Term Budget Challenges’ with Novo’s Rybelsus
Xtalks
Tue, 12/10/19 - 10:35 am
Novo Nordisk
Rybelsus
oral semaglutide
diabetes
ICER
drug pricing
Novo drops oral GLP-1 analog to focus on next-gen Rybelsus
Fierce Biotech
Fri, 11/1/19 - 10:36 am
Novo Nordisk
diabetes
OG2023SC
Rybelsus
oral semaglutide
How Big Can This $8 Billion-Plus Diabetes Drug Class Get?
Motley Fool
Fri, 09/27/19 - 09:10 am
diabetes
Eli Lilly
Merck
Novo Nordisk
GSK
Byetta
Victoza
Bydureon
Ozempic
Tanzeum
Trulicity
Rybelsus
Novo’s new oral GLP-1 Rybelsus still has obstacles to overcome
Pharmaforum
Tue, 09/24/19 - 09:53 am
Novo Nordisk
oral semaglutide
Rybelsus
FDA
Novo Nordisk wins FDA green light for 'holy grail' diabetes drug Rybelsus
Fierce Pharma
Fri, 09/20/19 - 01:13 pm
Novo Nordisk
oral semaglutide
FDA
Rybelsus
type 2 diabetes